• Skip to primary navigation
  • Skip to main content
  • Skip to footer

RAIRDA HomepageRAIRDA

The Rare Autoimmune Rheumatic Disease Alliance

  • About us
    • Our members
    • About RAIRDs
    • Our board
    • Our story
  • What we do
    • Our priorities
    • A Quality Standard for Rare Disease
    • Publications
  • News
  • Get involved
    • Personal Stories
    • Share your story
    • Campaign for us
  • Contact us
  • Search

RAIRDA

Survey shows poor communication around COVID-19 vaccine and treatments for people with rheumatic conditions

We would like to thank everybody who took part in our survey of people with rheumatic conditions about the fourth coronavirus (COVID-19) vaccination dose. The...

RAIRDA launches fourth vaccination dose survey

RAIRDA and its member charities have launched a short survey aimed at all adults with a rheumatic condition in the UK. We want to understand whether...

Safe At Work: letter to employers, March 2022

We have published a safe at work letter for people with rheumatic diseases who are located in England and are at higher risk from Covid-19...

Take action against ending free COVID-19 testing kits

Join us in calling on the UK Government to continue free tests for people who are eligible for COVID-19 treatments, their families and close contacts....

MELODY Study: An Overview

The MELODY (Mass evaluation of lateral flow immunoassays for the detection of SARS-CoV-2 antibody responses in immunosuppressed people) study will use home antibody testing to understand how well immunocompromised...

Online survey – Steroid PRO study

Are you being treated with steroids for your rheumatic condition? We need your help to test a new questionnaire about steroid impact on quality of...

Guidance on Covid-19 vaccination for the severely immunosuppressed

As the pandemic continues to develop and new variants emerge, we will be using this article to make sure everyone has access to important information...

New antibody treatments available for immunosuppressed patients

From the 16th December high risk patients (severely immunosuppressed) who have tested positive for COVID-19 and have onset of symptoms in the last 7 days...

Are you eligible for a third dose or a booster vaccine?

Third doses of the COVID-19 vaccine are being offered to severely immunosuppressed people, either because of a health condition or treatment. This is because research...

NHS online booking system updated to include third primary dose

We are pleased to see that NHS England have updated the COVID-19 vaccination booking system on their website to include a category for third primary...

Survey shows nearly a quarter of people with rheumatic conditions are struggling to get access to a vital third primary jab

RAIRDA and its member charities are calling for urgent government action to address concerns about the roll-out of third primary doses for the COVID-19 vaccine....

Charities launch rapid third primary vaccination dose survey

Along with a number of other charities, RAIRDA and its member charities are supporting a rapid survey aimed at all adults with a rheumatic condition in the UK. We...

Next Page »

Footer

  • Twitter

No Tweets found

Contact us

This website uses only essential cookies to ensure functionality. These cookies are strictly necessary for the website to operate and do not track your browsing activity beyond the site.I understand